Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021

SELL
$0.93 - $1.18 $2,697 - $3,422
-2,900 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$0.75 - $1.29 $28,841 - $49,606
-38,455 Reduced 92.99%
2,900 $2,000
Q1 2020

May 14, 2020

SELL
$0.33 - $1.62 $87 - $427
-264 Reduced 0.63%
41,355 $39,000
Q4 2019

Feb 14, 2020

BUY
$1.23 - $2.67 $31,722 - $68,861
25,791 Added 162.95%
41,619 $65,000
Q3 2019

Nov 14, 2019

BUY
$1.25 - $5.0 $7,942 - $31,770
6,354 Added 67.07%
15,828 $34,000
Q2 2019

Aug 14, 2019

SELL
$1.65 - $6.72 $10,193 - $41,516
-6,178 Reduced 39.47%
9,474 $18,000
Q1 2019

May 15, 2019

BUY
$4.84 - $9.07 $37,611 - $70,482
7,771 Added 98.6%
15,652 $108,000
Q4 2018

Feb 14, 2019

SELL
$4.21 - $14.28 $24,464 - $82,981
-5,811 Reduced 42.44%
7,881 $49,000
Q3 2018

Dec 21, 2021

BUY
$13.02 - $17.54 $20,727 - $27,923
1,592 Added 13.16%
13,692 $192,000
Q3 2018

Nov 14, 2018

BUY
$13.02 - $17.54 $157,542 - $212,234
12,100 New
12,100 $168,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $523M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.